Centrica shares are cheap after recent weakness, says JPMorgan

12:24, 21st February 2024

 [Ming - www.stock.adobe.com]

JPMorgan has maintained an 'overweight' position on energy and services company  , saying the stock's current valuation is "undemanding" given recent weakness.
Centrica's shares have declined more than 20% since the highs of around the 170p mark last September, with the stock having fallen by 8% in the 2024 so far.

That's despite beating company-provided consensus at both the earnings and net cash level at FY23 results last week, JPMorgan said.

"We believe that the weakness has been driven by positioning - many hedge fund investors were long the shares last summer - as well as lower earnings expectations from the buy-side as commodity prices have decreased," the bank said on Wednesday in a research note.

"In our view, the current share price implies that Centrica's medium-term earnings will be 25% below guidance, and that the company will destroy over £1bn of value in future investments and growth capex. We continue to see Centrica as well positioned to deliver on its targets, without being reliant on elevated commodity prices, volatility or an accelerated energy transition scenario."

JPMorgan said the stock trades at a multiple of under three in terms of an enterprise value-to-EBITDA valuation, and its 190p target price for the shares implies 43% upside and was calculated assuming no value creation from the company's growth investments.

Meanwhile, with Centrica's current £1bn share buyback programme due to end this summer, JPMorgan said it sees scope for a further £500m "which could be a catalyst that drives a rerating".

The stock was down 2.4% at 130.15p by 1129 GMT.

TwitterFacebookLinkedIn

Disclaimer & Declaration of Interest

The information, investment views and recommendations in this article are provided for general information purposes only. Nothing in this article should be construed as a solicitation to buy or sell any financial product relating to any companies under discussion or to engage in or refrain from doing so or engaging in any other transaction. Any opinions or comments are made to the best of the knowledge and belief of the writer but no responsibility is accepted for actions based on such opinions or comments. Vox Markets may receive payment from companies mentioned for enhanced profiling or publication presence. The writer may or may not hold investments in the companies under discussion.

Watchlist